Sign In |Help & Support
ALL SECTORS
  • ALL SECTORS
  • GB(National Standard)
  • CB(Shipping)
  • CECS(Engineering Construction)
  • CJ(Urban Construction)
  • CY(News and Publication)
  • DB(Provincial Standard)
  • DL(Electricity & Power)
  • DZ(Geology & Mineralogy)
  • FZ(Spinning & Textile)
  • GA(Public Security)
  • HB(Aviation)
  • HG(Chemical Industry)
  • HJ(Environmental Protection)
  • JB(Machinery)
  • JC(Building Materials)
  • JG(Building & Construction)
  • JJ(Metering)
  • JT(Highway & Transportation)
  • LY(Forestry)
  • MT(Coal)
  • NB(Energy)
  • NY(Agriculture)
  • QB(Light Industry)
  • QC(Automobile & Vehicle)
  • QJ(Aerospace)
  • SH(Petrochemical)
  • SJ(Electronics)
  • SL(Water Resources)
  • SN(Commodity Inspection)
  • SY(Oil & Gas)
  • TB(Railway & Train)
  • YB(Ferrous Metallurgy)
  • YC(Tobacco)
  • YD(Telecommunication)
  • YY(Medical Device)
Database: 365,228(8 Aug 2026)

Drugs for Rare Diseases

Drugs for Rare Diseases, Total:173 items.

The international standard classification for "Drugs for Rare Diseases" includes: Medical Sciences and health care facilities in general , Transport by water .

The Chinese standard classification for "Drugs for Rare Diseases" includes: Medical science , Diving and its physiological condition , Diagnostic standard for public nuisance diseases .


Jiangsu Provincial Standard of the People's Republic of China

  • DB32/T 4688.9-2024 Technical Guidelines for AIDS Prevention and Treatment Part 9: Drug Maintenance Treatment
  • DB32/T 4698-2024 Standardization of diagnostic and treatment paths for treating pre-diseases with traditional Chinese medicine
  • DB32/T 4250-2021 Technical specifications for quality control of HIV antiretroviral treatment
  • DB32/T 4688.9-2024 Technical Guidelines for AIDS Prevention and Treatment Part 9: Drug Maintenance Treatment
  • DB32/T 4187-2021 Technical specification for quality control of AIDS antiretroviral treatment

Group Standards of the People's Republic of China

  • T/SAME 003-2023 Standard for quality control of theraputic drug monitoring in neuropsychopharmacology
  • T/CMAM W3-2022 Diagnosis and Treatment Guidelines for Common Diseases in Uyghur Medicine
  • T/CHATA 031-2023 Chemotherapy for Drug-Resistant Tuberculosis in Children and Adolescents
  • T/CAPC 012-2023 Standards for pharmaceutical care of retail pharmacies supplying diabetes, hypertension and dyslipidemia medications
  • T/CACM 012-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for sepsis
  • T/CMAM K 13-2022 Diagnosis and Treatment Guidelines for Common Diseases of Kazakh Medicine Gynecology
  • T/TIC 015-2023 Rheumatism treatment technical specifications
  • T/CAPC 015-2024 Specification for pharmaceutical care of pharmacies retailing thyroid disease medications
  • T/CHSA 013-2023 Guidelines of orthodontic treatment for patients with periodontitis
  • T/CHAS 20-2-11-2022 Pharmacy administration and Pharmacy practice in Healthcare institutions—— Part 2-11: Pharmacy practice——Therapeutic drug monitoring
  • T/CACM 009-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute upper respiratory tract infection in children
  • T/CHATA 041-2024 Treatment guidelines for rifampicin-resistant tuberculosis
  • T/CACM 1570.4-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials?—?Salviae Miltiorrhizae Radix et Rhizoma (Salvia miltiorrhiza Bunge)
  • T/CACM 010-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for pelvic inflammatory disease
  • T/CACM 1104-2018 Technical Operation Standards for Preventive Treatment of Diseases in Traditional Chinese Medicine
  • T/CACM 011-2016 Simple lower urinary tract infection
  • T/CACM 1570.2-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials— Asia ginseng (Panax ginseng C. A. Meyer)
  • T/LZSZZHY 010-2024 Technical specifications for prevention and treatment of common Tibetan pig diseases
  • T/CHATA 021-2022 Drug treatment guidelines for different grades of liver injury caused by anti-tuberculosis drugs
  • T/SAIA 006-2022 Technical specification for comprehensive control of common diseases of equine animals
  • T/CAPC 014-2023 Standards for pharmaceutical care of retail pharmacies supplying psoriasis medications
  • T/CACM 006-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for community-acquired pneumonia
  • T/SATCM 0005-2025 Expert consensus on acupuncture treatment for diabetic peripheral neuropathy
  • T/GXAS 660-2023 Specification for traditional Chinese medicine external treatment of acquired immuno deficiency syndrome common diseases
  • T/CVMA 64-2021 Guidelines for the Treatment of Chronic Kidney Disease in Dogs and Cats
  • T/CADERM 3012-2019 Specifications for diagnosis and treatment of rabies
  • T/CMAM T28-35-2019 Evaluating Criteria for Curative Effect of Common Diseases of Tujia Medicine
  • T/CACM 1447-2023 Intervention guidelines for prevention of winter diseases in summer using acupoint application therapy
  • T/CACM 1570.3-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials— Chuanxiong Rhizoma(Ligusticum chuanxiong Hort.)
  • T/CACM 1570.1-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials — General principles
  • T/CACM 1570.6-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials—Angelica sinensis Radix[Angelica sinensis (Oliv.) Diels]
  • T/CHATA 033-2024 Guidelines for the Treatment and Management of Patients with Concurrent Tuberculosis and Diabetes Mellitus
  • T/CMAM M1-M9-2018 Diagnosis and Treatment Guidelines for Common Diseases of Mongolian Medicine
  • T/CACM 1570.5-2024 Technical specification for integrated management of diseases of plant Chinese medicinal materials?—?Rehmanniae Radix (Rehmannia glutinosa Libosch.)
  • T/CMAM T20-27-2019 Diagnosis and Treatment Guidelines for Common Diseases of Tujia Medicine
  • T/CACM 1105-2018 Traditional Chinese medicine medicine bath
  • T/LZZLXH 50-2021 Technical specifications for prevention and control of common diseases in Tibetan pigs
  • T/CACM 008-2018 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute pharyngitis
  • T/CMAM K 14-2022 Diagnosis and Treatment Guidelines for Common Diseases of Kazakh Medicine Orthopedics
  • T/CACM 1101-2018 Technical Operation Standards for Prevention and Treatment of Traditional Chinese Medicine
  • T/TIC 012-2023 Pain treatment system
  • T/CACM 007-2017 Clinical practice guidelines for the treatment of common infectious diseases with traditional Chinese medicine alone/combined with antibiotics for acute tonsillitis
  • T/CLPA 003-2023 Pharmaceutical Service Guidelines for Endocrine Therapy of Breast Cancer (2023 Edition)

Guangxi Provincial Standard of the People's Republic of China

  • DB45/T 2790-2023 Zhuang Medicine Bamboo Pot Treatment and Nursing Technical Operation Specifications
  • DB45/T 2113-2020 Zhuang medicine acupoints combined with drug hot ironing therapy for Pangbayin technical specifications
  • DB45/T 1087.3-2017 Technical regulations for diagnosis and treatment of common freshwater cultured fish diseases Part 3: Drug efficacy test for disease prevention and control
  • DB45/T 2786-2023 Technical specifications of Zhuang medicine bamboo pot therapy for the treatment of knee osteoarthritis

General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China

  • GB/T 17870-1999 Technical requirements of recompression therapy for decompression sickness
  • GB/T 31720-2015 Insecticide resistance management for vector―General rules

Shanxi Provincial Standard of the People's Republic of China

  • DB1410/T 129-2022 Technical specification for prevention and control of common garden plant diseases and insect pests

Professional Standard - Agriculture

Professional Standard - Hygiene

  • WS/T 77-1996 Principles of management on Keshan disease
  • WS/T 79-2011 Assessment for therapeutic efficacy on Kashin-Beck disease
  • WS/T 314-2009 Principles of management and criteria of evaluating curative effects of Keshan disease
  • WS/T 79-1996 The judging of treatment effect on Kashin-beck disease

Hebei Provincial Standard of the People's Republic of China

  • DB13/T 715-2005 Technical regulations for the prevention and treatment of common stomach diseases in dairy cows
  • DB13/T 1375-2011 Technical regulations for the prevention and treatment of common skin infectious diseases of fur animals

Beijing Provincial Standard of the People's Republic of China

  • DB11/T 196-2013 Common fish disease control technical operation rules
  • DB11/T 157.8-2008 Technical Specifications for Rainbow Trout Breeding Part 8: Diagnosis and Treatment of Common Diseases and Safe Medication
  • DB11/T 196-2003 rules of prevention and cure for familiar disease of fish

Anhui Provincial Standard of the People's Republic of China

  • DB34/T 2116-2014 Technical regulations on prevention and treatment of chestnut plaster disease
  • DB34/T 4425-2023 Guidelines for the construction of therapeutic drug monitoring laboratories in medical institutions

Jilin Provincial Standard of the People's Republic of China

  • DB22/T 2585-2016 Traditional Chinese medicine fumigation washing treatment machine

Hubei Provincial Standard of the People's Republic of China

  • DB42/T 2083.1-2023 Technical Regulations for Biological Control of Main Pests and Diseases of Traditional Chinese Medicinal Plants Part 1: Coptis Rhizome
  • DB42/T 1640-2021 Technical regulations for biological control of main diseases and insect pests of Chinese herbal medicine Atractylodes macrocephala
  • DB42/T 2083.2-2024 Chinese Traditional Medicinal Materials and Pharmaceutical Plants - Biological Control Techniques for Main Diseases and Pests - Part 2: Pinxia (Pinellia ternata)

Code of Federal Regulations (CFR)

  • CFR 21-316.23-2013 Food and drugs. Part316:Orphan drugs. Section316.23:Timing of requests for orphandrug designation; designation of already approved drugs.
  • CFR 21-316.29-2013 Food and drugs. Part316:Orphan drugs. Section316.29:Revocation of orphan-drug designation.
  • CFR 21-890.5150-2013 Food and Drugs. Part890:Physical medicine devices. Section890.5150:Powered patient transport.
  • CFR 21-316.28-2013 Food and drugs. Part316:Orphan drugs. Section316.28:Publication of orphan-drug designations.
  • CFR 21-316.3-2013 Food and drugs. Part316:Orphan drugs. Section316.3:Definitions.
  • CFR 21-316.21-2013 Food and drugs. Part316:Orphan drugs. Section316.21:Verification of orphan-drug status.
  • CFR 21-316.50-2013 Food and drugs. Part316:Orphan drugs. Section316.50:Guidance documents.
  • CFR 21-316.31-2013 Food and drugs. Part316:Orphan drugs. Section316.31:Scope of orphan-drug exclusive approval.
  • CFR 21-316.26-2013 Food and drugs. Part316:Orphan drugs. Section316.26:Amendment to orphan-drug designation.
  • CFR 21-316.4-2013 Food and drugs. Part316:Orphan drugs. Section316.4:Address for submissions.
  • CFR 21-316.25-2013 Food and drugs. Part316:Orphan drugs. Section316.25:Refusal to grant orphan-drug designation.
  • CFR 21-316.24-2013 Food and drugs. Part316:Orphan drugs. Section316.24:Deficiency letters and granting orphan-drug designation.
  • CFR 21-316.1-2013 Food and drugs. Part316:Orphan drugs. Section316.1:Scope of this part.
  • CFR 21-316.22-2013 Food and drugs. Part316:Orphan drugs. Section316.22:Permanent-resident agent for foreign sponsor.

British Standards Institution (BSI)

US Federal Contractor Registration (USFCR)

International Organization for Standardization (ISO)

  • ISO 21549-7:2007 Health informatics - Patient healthcard data - Part 7: Medication data

Magyar Szabványügyi Testület

German Institute for Standardization

Gosstandart of Russia

  • GOST 33280-2015 Medicine remedies for veterinary use. Vaccine against leptospirosis of animals. Specifications
  • GOST R 52682-2006 Medicine remedies for veterinary use. Terms and definitions
  • GOST 33459-2015 Medicine remedies for veterinary use. Vaccines against dermatophytosis of animals. General specification
  • GOST R 52683-2006 Medicine remedies for veterinary use. Packing, marking, transportation and storage
  • GOST R 52684-2006 Medicine remedies for animals. Acceptance rules, methods of sampling
  • GOST 33275-2015 Biological medicine remedies for veterinary use. Vaccines fowl pox. Specifications

Austrian Standards

Standards New Zealand

American Water Works Association (AWWA)

Korean Agency for Technology and Standards (KATS)